GH1 and adenoma: Surgical resection of the adenoma is the first-line approach for most patients, with normalization of age-adjusted IGF-1 concentrations and reduction of GH concentrations to < 1 μg/L (or < 0.4 μg/L with ultrasensitive assays) being the primary therapeutic target [2].